Welcome to LookChem.com Sign In|Join Free

CAS

  • or
BOC-L-Tyrosine, also known as N-Boc-L-tyrosine, is an N-Boc-protected form of L-Tyrosine, an essential amino acid. It exhibits in vitro antioxidant and antiradical activities, playing a crucial role in various biological processes and functions.

3978-80-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3978-80-1 Structure
  • Basic information

    1. Product Name: BOC-L-Tyrosine
    2. Synonyms: BOC-L-Tyrosine, 99+% 5GR;N-Boc-L-tyrosine Boc-Tyr-OH;Boc-Tyr-OH 98%;Boc-L-tyrosine≥ 98% (HPLC);L-TYROSINE, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-;BOC-TYR-OH;BOC-TYROSINE;BOC-TYROSINE-OH
    3. CAS NO:3978-80-1
    4. Molecular Formula: C14H19NO5
    5. Molecular Weight: 281.3
    6. EINECS: 223-613-7
    7. Product Categories: Amino Acid Derivatives;Amino Acids;Tyrosine [Tyr, Y];Boc-Amino Acids and Derivative;Amino Acids (N-Protected);Biochemistry;Boc-Amino Acids;Boc-Amino acid series
    8. Mol File: 3978-80-1.mol
  • Chemical Properties

    1. Melting Point: 133-135 °C(lit.)
    2. Boiling Point: 423.97°C (rough estimate)
    3. Flash Point: 247.1 °C
    4. Appearance: White to off-white/Powder
    5. Density: 1.1755 (rough estimate)
    6. Vapor Pressure: 3.23E-10mmHg at 25°C
    7. Refractive Index: 1.5230 (estimate)
    8. Storage Temp.: −20°C
    9. Solubility: DMSO (Slightly), Methanol (Sparingly)
    10. PKA: 2.98±0.10(Predicted)
    11. BRN: 2816406
    12. CAS DataBase Reference: BOC-L-Tyrosine(CAS DataBase Reference)
    13. NIST Chemistry Reference: BOC-L-Tyrosine(3978-80-1)
    14. EPA Substance Registry System: BOC-L-Tyrosine(3978-80-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 22-24/25-36-26
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 3978-80-1(Hazardous Substances Data)

3978-80-1 Usage

Uses

Used in Pharmaceutical Industry:
BOC-L-Tyrosine is used as a precursor for the synthesis of catecholamines, such as Norepinephrine HCl, in human keratinocytes. It is essential for the production of these neurotransmitters, which are vital for the proper functioning of the central and peripheral nervous systems.
Used in Nutritional Supplements:
BOC-L-Tyrosine is used as a nutritional supplement to support the body's natural production of proteins and thyroid hormones. Its antioxidant and antiradical properties also contribute to overall health and well-being.
Used in Chemical Synthesis:
BOC-L-Tyrosine serves as a key intermediate in the chemical synthesis of various compounds, including pharmaceuticals and other bioactive molecules. Its chemical properties as a white to off-white powder make it a versatile and stable starting material for a wide range of chemical reactions.

Check Digit Verification of cas no

The CAS Registry Mumber 3978-80-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,7 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 3978-80:
(6*3)+(5*9)+(4*7)+(3*8)+(2*8)+(1*0)=131
131 % 10 = 1
So 3978-80-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H19NO5/c1-14(2,3)20-13(19)15-11(12(17)18)8-9-4-6-10(16)7-5-9/h4-7,11,16H,8H2,1-3H3,(H,15,19)(H,17,18)/p-1/t11-/m0/s1

3978-80-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B1640)  N-(tert-Butoxycarbonyl)-L-tyrosine  >98.0%(HPLC)(T)

  • 3978-80-1

  • 10g

  • 760.00CNY

  • Detail
  • TCI America

  • (B1640)  N-(tert-Butoxycarbonyl)-L-tyrosine  >98.0%(HPLC)(T)

  • 3978-80-1

  • 25g

  • 1,390.00CNY

  • Detail
  • Alfa Aesar

  • (A10810)  N-Boc-L-tyrosine, 98+%   

  • 3978-80-1

  • 1g

  • 191.0CNY

  • Detail
  • Alfa Aesar

  • (A10810)  N-Boc-L-tyrosine, 98+%   

  • 3978-80-1

  • 5g

  • 549.0CNY

  • Detail
  • Alfa Aesar

  • (A10810)  N-Boc-L-tyrosine, 98+%   

  • 3978-80-1

  • 25g

  • 2329.0CNY

  • Detail
  • Aldrich

  • (374229)  Boc-Tyr-OH  98%

  • 3978-80-1

  • 374229-5G

  • 668.07CNY

  • Detail

3978-80-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate

1.2 Other means of identification

Product number -
Other names N-tert-butoxycarbonyl-L-tyrosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3978-80-1 SDS

3978-80-1Downstream Products

3978-80-1Relevant articles and documents

Palladium on carbon encapsulated in POEPOP1500: A resin-supported catalyst for hydrogenation reactions

Jansson, Anita M.,Grotli, Morten,Halkes, Koen M.,Meldal, Morten

, p. 27 - 30 (2002)

(formula presented) A new a versatile catalyst for hydrogenation reactions wherein palladium on arbon is encapsulated in POEPOP1500-resin is described. This polymer-supported catalyst has been successfully used in solution phase hydrogenation of a double and a triple bond as well as hydrogenolysis of a benzyl-protecting group. While the activity of the new catalyst is marginally lower than standard 10% Pd/C, it has the advantage of being reused several times without significant loss of reactivity.

An efficient synthesis of N-tert-butoxycarbonyl-O-cyclohexyl-L-tyrosine

Nishiyama,Ishizuka,Shikama,Kurita

, p. 233 - 235 (2001)

A facile and efficient synthesis of N-tert-butoxycarbonyl-O-cyclohexyl-L-tyrosine (Boc-Tyr(Chx)-OH] is described. Boc-Tyr-OH was treated with NaH in dimethylformamide and then with 3-bromocyclohexene to give N-Boc-O-(cyclohex-2-enyl)-L-tyrosine [Boc-Tyr(Che)-OH] in 70% yield. Hydrogenation of Boc-Tyr(Che)-OH over PtO2 afforded Boc-Tyr(Chx)-OH in almost quantitative yield. The highest yield was achieved when a side product in the synthesis of Boc-Tyr-OH, Boc-Tyr(Boc)-OH, was not removed, because it was also converted to Boc-Tyr(Che)-OH without any additional manipulations. The new synthetic method described here is couvenient for practical use, and would facilitate the widespread use of the Chx group for the hydroxy-protection of Tyr.

Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts

Le Manach, Claire,Dam, Jean,Woodland, John G.,Kaur, Gurminder,Khonde, Lutete P.,Brunschwig, Christel,Njoroge, Mathew,Wicht, Kathryn J.,Horatscheck, André,Paquet, Tanya,Boyle, Grant A.,Gibhard, Liezl,Taylor, Dale,Lawrence, Nina,Yeo, Tomas,Mok, Sachel,Eastman, Richard T.,Dorjsuren, Dorjbal,Talley, Daniel C.,Guo, Hui,Simeonov, Anton,Reader, Janette,Van Der Watt, Mari?tte,Erlank, Erica,Venter, Nelius,Zawada, Jacek W.,Aswat, Ayesha,Nardini, Luisa,Coetzer, Theresa L.,Lauterbach, Sonja B.,Bezuidenhout, Belinda C.,Theron, Anjo,Mancama, Dalu,Koekemoer, Lizette L.,Birkholtz, Lyn-Marie,Wittlin, Sergio,Delves, Michael,Ottilie, Sabine,Winzeler, Elizabeth A.,Smith, Dennis,Fidock, David A.,Street, Leslie J.,Basarab, Gregory S.,Duffy, James,Chibale, Kelly

supporting information, p. 2291 - 2309 (2021/03/01)

A novel diazaspiro[3.4]octane series was identified from a Plasmodium falciparum whole-cell high-throughput screening campaign. Hits displayed activity against multiple stages of the parasite lifecycle, which together with a novel sp3-rich scaffold provided an attractive starting point for a hit-to-lead medicinal chemistry optimization and biological profiling program. Structure-activity-relationship studies led to the identification of compounds that showed low nanomolar asexual blood-stage activity (50 nM) together with strong gametocyte sterilizing properties that translated to transmission-blocking activity in the standard membrane feeding assay. Mechanistic studies through resistance selection with one of the analogues followed by whole-genome sequencing implicated the P. falciparum cyclic amine resistance locus in the mode of resistance.

Transition-metal ion-mediated morphological transformation of pyridine-based peptide nanostructures

Singh, Narendra,Singh, Ramesh,Sharma, Swati,Kesharwani, Khushboo,Joshi, Khashti Ballabh,Verma, Sandeep

supporting information, p. 153 - 161 (2021/01/11)

Inspired by natural metallopeptides, we have rationally designed two pyridine-conjugated short peptides. These two peptide conjugates formed a pair of constitutional isomers that helped us describe their structure-function relationship. Both the isomers consisted of an equal number of aromatic amino acid residues, but shuffling was observed in the position of two key amino acids, viz; tyrosine and phenylalanine, which brought a remarkable change in their self-assembling behavior. The presence of specific functional groups and chemical diversity in both conjugates made them very active towards metal coordination. Both the constitutional isomers adopted different pathways of self-assembly, which could be further controlled or transformed by the use of transition metal ions. Interestingly, it was observed that the metal ions could precisely control the morphology of these metallopeptide nanostructures and make them more stable. Therefore, such artificial metallopeptides possess remarkable advantages over the natural counterparts primarily due to their tailor-made chemical structures.

Synthesis, in vitro ADME profiling and in vivo pharmacological evaluation of novel glycogen phosphorylase inhibitors

Miao, Guang-xin,Wang, You-de,Yan, Zhi-wei,Zhang, Li-ying

supporting information, (2020/05/18)

A small set of indole-2-carboxamide derivatives identified from a high-throughput screening campaign has been described as a novel, potent, and glucose-sensitive inhibitors of glycogen phosphorylase a (GPa). Among this series of compounds, compound 2 exhibited moderate GP inhibitory activity (IC50 = 0.29 μM), good cellular efficacy (IC50 = 3.24 μM for HepG2 cells and IC50 = 7.15 μM for isolated rat hepatocytes), together with good absorption, distribution, metabolism, and elimination (ADME) profiles. The in vivo animal study revealed that compound 2 significantly inhibited an increase of fasting blood glucose level in adrenaline-induced diabetic mice.

Semisynthesis of a Bacterium with Non-canonical Cell-Wall Cross-Links

Chen, Jason S.,Dik, David A.,Schultz, Peter G.,Webb, Bill,Zhang, Nan

supporting information, p. 10910 - 10913 (2020/07/08)

The cell wall is an elaborate framework of peptidoglycan that serves to protect the bacterium against osmotic challenge. This exoskeleton is composed of repeating saccharides covalently cross-linked by peptide stems. The general structure of the cell wall is widely conserved across diverse Gram-negative bacteria. To begin to explore the biological consequence of introducing non-canonical cross-links into the cell wall of Escherichia coli, we generated a bacterium where up to 31percent of the cell-wall cross-links are formed by a non-enzymatic reaction between a sulfonyl fluoride and an amino group. Bacteria with these non-canonical cell-wall cross-links achieve a high optical density in culture, divide and elongate successfully, and display no loss of outer membrane integrity. This work represents a first step in the design of bacteria with non-canonical "synthetic"cell walls.

Synthesis of pyrimidine nucleoside and amino acid conjugates

Koplūnait?, Martyna,Butkut?, Kamil?,Me?kys, Rolandas,Taurait?, Daiva

supporting information, (2020/11/13)

The synthesis of novel pyrimidine nucleoside bioconjugates with amino acids is presented. The N4-amino acid-acylated 2′-deoxycytidine analogues, modified with various amino acids, were synthesized using a three-step synthesis and obtained in moderate overall yields. Novel amino acid-alkylated 2′-deoxycytidine derivatives were obtained during the rearrangement of amino acid-acylated derivatives that occurred during Boc deprotection.

Total Synthesis of Herquline B and C

Cox, Joshua B.,Kimishima, Aoi,Wood, John L.

supporting information, p. 25 - 28 (2019/01/16)

The total syntheses of (-)-herquline B (2) and a heretofore-unrecognized congener, (+)-herquline C (3), are described. The syntheses require 14 and 13 steps, respectively, and feature a key oxazoline reduction that sets the stage for piperazine construction.

α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease

Moreno-Cinos, Carlos,Sassetti, Elisa,Salado, Irene G.,Witt, Gesa,Benramdane, Siham,Reinhardt, Laura,Cruz, Cristina D.,Joossens, Jurgen,Van Der Veken, Pieter,Br?tz-Oesterhelt, Heike,Tammela, P?ivi,Winterhalter, Mathias,Gribbon, Philip,Windshügel, Bj?rn,Augustyns, Koen

, p. 774 - 797 (2019/01/30)

Increased Gram-negative bacteria resistance to antibiotics is becoming a global problem, and new classes of antibiotics with novel mechanisms of action are required. The caseinolytic protease subunit P (ClpP) is a serine protease conserved among bacteria that is considered as an interesting drug target. ClpP function is involved in protein turnover and homeostasis, stress response, and virulence among other processes. The focus of this study was to identify new inhibitors of Escherichia coli ClpP and to understand their mode of action. A focused library of serine protease inhibitors based on diaryl phosphonate warheads was tested for ClpP inhibition, and a chemical exploration around the hit compounds was conducted. Altogether, 14 new potent inhibitors of E. coli ClpP were identified. Compounds 85 and 92 emerged as most interesting compounds from this study due to their potency and, respectively, to its moderate but consistent antibacterial properties as well as the favorable cytotoxicity profile.

PREPARATION AND USES OF REACTIVE OXYGEN SPECIES SCAVENGER DERIVATIVES

-

Page/Page column 111, (2019/03/07)

Compounds of Formula (I) a or (I) b: including certain quinone derivatives, and the corresponding pharmaceutical compositions, which may serve to modulate ferroptosis in a subject. Also disclosed herein are the preparations of these compounds and pharmaceutical compositions and their potential uses in the manufacture of a medicament in reducing reactive oxygen species (ROS) in a cell and for preventing, treating, ameliorating certain related disorder or a disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3978-80-1